Skip to main content

Advertisement

SpringerLink
Log in

Genetics of diabetic nephropathy in the pima indians

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Diabetic nephropathy is the leading cause of renal failure in industrialized countries. There is strong evidence that diabetic nephropathy is influenced by genetic factors. Studies in the Pima Indians as well as in other populations demonstrate that diabetic nephropathy aggregates in families. The hypothesis that the familial aggregation reflects the effect of a major gene was formally tested by segregation analysis of diabetic nephropathy in Pima Indians with type 2 diabetes.

The segregation analysis provided strong evidence for a major genetic effect on the prevalence of diabetic nephropathy; this suggests that some of the genetic determinants of diabetic nephropathy may have effects of sufficient magnitude to be detected by linkage analysis. Therefore, we analyzed data from a genome-wide scan to identify susceptibility loci for nephropathy in diabetic Pima Indians. Analyses conducted by both parametric (model-based) and nonparametric methods revealed tentative evidence for nephropathy susceptibility loci on chromosomes 3q, 7q, 18q, and 20p.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. U. S. Renal Data System. 1999 annual data report [no authors listed]. Am J Kidney Dis 1999, 34(2 suppl 1):S9–S19.

  2. Ritz E, Orth RS: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 2000, 341:1127–1133.

    Article  Google Scholar 

  3. Knowler WC, Pettitt DJ, Hamman RF, Miller M: Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester Minnesota. Am J Epidemiol 1978, 108:497–505.

    PubMed  CAS  Google Scholar 

  4. Knowler WC, Bennett PH, Bottazzo GF, et al.: Islet cell antibodies and diabetes mellitus in Pima Indians. Diabetologia 1979, 17:161–164.

    Article  PubMed  CAS  Google Scholar 

  5. Dabelea D, Palmer JP, Bennett PH, et al.: Absence of glutamic acid decarboxylase antibodies in Pima Indian children with diabetes mellitus. Diabetologia 1999, 42:1265–1266.

    Article  PubMed  CAS  Google Scholar 

  6. Nelson RG, Newman JM, Knowler WC, et al.: Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia 1988, 31:730–736.

    Article  PubMed  CAS  Google Scholar 

  7. Sievers ML, Nelson RG, Knowler WC, et al.: Impact of non-insulin dependent diabetes mellitus on mortality and causes of death in Pima Indians. Diabetes Care 1992, 15:1541–1549.

    Article  PubMed  CAS  Google Scholar 

  8. Ginsberg JM, Chang BS, Matarese RS, et al.: Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983, 309:1543–1546.

    Article  PubMed  CAS  Google Scholar 

  9. Nelson RG, Knowler WC, Pettitt DJ, et al.: Kidney disease in diabetes. In Diabetes in America, edn 2. Edited by Harris MI. Bethesda, MD: National Institutes of Health; 1995:349–400.

    Google Scholar 

  10. Nelson RG, Knowler WC, Pettitt DJ, et al.: Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 1991, 151:1761–1765.

    Article  PubMed  CAS  Google Scholar 

  11. Nelson RG, Knowler WC, McCance DR, et al.: Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria. Diabetologia 1993, 36:1087–1093.

    Article  PubMed  CAS  Google Scholar 

  12. Nelson RG, Bennett PH, Beck GJ, et al.: Development and progression of renal disease in Pima Indians with noninsulin dependent diabetes mellitus. N Engl J Med 1996, 335:1636–1642.

    Article  PubMed  CAS  Google Scholar 

  13. Pagtalunan ME, Miller PL, Jumping-Eagle S, et al.: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997, 99:342–348.

    PubMed  CAS  Google Scholar 

  14. Pugh JA, Medina R, Ramirez M: Comparison of the course of end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia 1993, 36:1094–1098.

    Article  PubMed  CAS  Google Scholar 

  15. Gall MA, Rossing P, Skøtt P, et al.: Prevalence of microalbuminuria, arterial hypertension, retinopathy, and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991, 34:655–661.

    Article  PubMed  CAS  Google Scholar 

  16. Nelson RG, Kunzelman CL, Pettitt DJ, et al.: Albuminuria in type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians. Diabetologia 1989, 32:870–876.

    Article  PubMed  CAS  Google Scholar 

  17. Ravid M, Brosh D, Ravid-Safran D, et al.: Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure and hyperglycemia. Arch Intern Med 1998, 158:998–1004.

    Article  PubMed  CAS  Google Scholar 

  18. Nelson RG, Knowler WC, Pettitt DJ, et al.: Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM. Diabetes Care 1995, 18:182–187.

    Article  PubMed  CAS  Google Scholar 

  19. Seaquist ER, Goetz FC, Rich S, et al.: Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989, 320:1161–1165.

    Article  PubMed  CAS  Google Scholar 

  20. Freedman BI, Tuttle AB, Spary BJ: Familial predisposition to nephropathy in African-Americans with non-insulindependent diabetes mellitus. Am J Kidney Dis 1995, 25:710–713.

    PubMed  CAS  Google Scholar 

  21. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996, 39:940–945.

    PubMed  CAS  Google Scholar 

  22. Faronato PP, Maioli M, Tonolo G, et al.: Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM. Diabetologia 1997, 40:816–823.

    Article  PubMed  CAS  Google Scholar 

  23. Canani LH, Gerchman F, Gross JL: Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes 1999, 48:909–913.

    Article  PubMed  CAS  Google Scholar 

  24. Forsblom CM, Kanninen T, Lehtovirta M, et al.: Heritability of albumin excretion rate in families of patients with type II diabetes. Diabetologia 1999, 42:1359–1366.

    Article  PubMed  CAS  Google Scholar 

  25. Vijay V, Snehalatha C, Shina K, et al.: Familial aggregation of diabetic kidney disease in type 2 diabetes in south India. Diabetes Res Clin Pract 1999, 43:167–171.

    Article  PubMed  CAS  Google Scholar 

  26. Pettitt DJ, Saad MF, Bennett PH, et al.: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990, 33:438–443.

    Article  PubMed  CAS  Google Scholar 

  27. Imperatore G, Knowler WC, Pettitt DJ, et al.: Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes 2000, 49:1049–1056. Shows that the familial aggregation of nephropathy in diabetic Pima Indians is consistent with the action of at least one major gene.

    Article  PubMed  CAS  Google Scholar 

  28. Fogarty DG, Hanna LS, Wantman M, et al.: Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes 2000, 49:1057–1063.

    Article  PubMed  CAS  Google Scholar 

  29. Elston RC: Linkage and association. Genet Epidemiol 1998, 15:565–576.

    Article  PubMed  CAS  Google Scholar 

  30. Knowler WC: Approaches to studying the genetics of type 2 diabetes. In Current Topics in Diabetes Research. Front Diabetes. Edited by Belfiore F et al. Basel, Switzerland: Kanger Press; 1993:1–11.

    Google Scholar 

  31. Durner M, Vieland VJ, Greenberg DA: Further evidence for the increased power of LOD scores compared with nonparametric methods. Am J Hum Genet 1999, 64:281–289.

    Article  PubMed  CAS  Google Scholar 

  32. Dizier MH, Babron MC, Clerget-Darpoux F: Conclusion of LOD-score analysis for family data generated under two-locus models. Am J Hum Genet 1996, 58:1338–1346.

    PubMed  CAS  Google Scholar 

  33. Rogus JJ, Krolewski AS: Using discordant sib pairs to map loci for qualitative traits with high sibling recurrence risk. Am J Hum Genet 1996, 59:1376–1381.

    PubMed  CAS  Google Scholar 

  34. Terwilliger JD, Ott J: Parametric analysis of complex diseases. In Handbook of Human Genetic Linkage. Edited by Terwilliger JD, Ott J. Baltimore, MD: The Johns Hopkins University Press; 1994:211–226.

    Google Scholar 

  35. Hanson RL, Ehm MG, Pettitt DJ, et al.: An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 1998, 63:1130–1138. Represents a large genomic scan to identify loci influencing susceptibility to diabetes and obesity in the Pima Indians. A diabetessusceptibility locus was identified on chromosome 1q and a diabetesobesity locus on chromosome 11q.

    Article  PubMed  CAS  Google Scholar 

  36. Imperatore G, Hanson RL, Pettitt DJ, et al.: Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes 1998, 47:821–830. Depicts to our knowledge the first genomic scan to identify diabetic nephropathy susceptibility genes. Tentative evidence for linkage was seen on chromosomes 3q, 7q, and 20p.

    Article  PubMed  CAS  Google Scholar 

  37. Elston RC: Genetic analysis workshop II: sib-pair screening tests for linkage. Genet Epidemiol 1984, 1:175–178.

    Article  PubMed  CAS  Google Scholar 

  38. Fogarty DG, Moczulski DK, Makita Y, et al.: Evidence for a susceptibility locus for diabetic nephropathy on chromosome 7q in Caucasian families with type 2 diabetes [abstract]. Diabetes 1999, 48(suppl 1):A47.

    Google Scholar 

  39. Cottingham RW, Idury RM, Schäffer AA: Faster sequential genetic linkage computations. Am J Hum Genet 1993, 53:252–263.

    PubMed  Google Scholar 

  40. Lathrop GM, Lalouel JM, Julier C, Ott J: Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A 1984, 81:3443–3446.

    Article  PubMed  CAS  Google Scholar 

  41. Curtis D, Gurling H: A procedure for combining two-point lod scores into a summary multipoint map. Hum Hered 1993, 43:173–185.

    Article  PubMed  CAS  Google Scholar 

  42. Lander ES, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11:241–247.

    Article  PubMed  CAS  Google Scholar 

  43. Davis S, Weeks DE: Comparison of nonparametric statistics for detection of linkage in nuclear families: single-marker evaluation. Am J Hum Genet 1997, 61:1431–1444.

    Article  PubMed  CAS  Google Scholar 

  44. Greenwood CMT, Bull SB: Down-weighting of multiple affected sib pairs leads to biased likelihood-ratio test, under the assumption of no linkage. Am J Hum Genet 1999, 64:1248–1252.

    Article  PubMed  CAS  Google Scholar 

  45. Moczulski DK, Rogus JJ, Antonellis A, et al.: Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes 1998, 47:1164–1169.

    Article  PubMed  CAS  Google Scholar 

  46. Heesom AE, Hibberd ML, Millward A, Demaine AG: Polymorphism in the 5’-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 1997, 46:287–291.

    Article  PubMed  CAS  Google Scholar 

  47. Moczulski DK, Burak W, Doria A, et al.: The role of aldose reductase gene in the susceptibility to diabetic nephropathy in type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1999, 42:94–97.

    Article  PubMed  CAS  Google Scholar 

  48. Moczulski DK, Scott L, Antonellis A, et al.: Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabet Med 2000, 17:111–118.

    Article  PubMed  CAS  Google Scholar 

  49. Zanchi A, Moczulski DK, Hanna LS, et al.: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000, 57:405–413.

    Article  PubMed  CAS  Google Scholar 

  50. Neugebauer S, Baba T, Watanabe T: Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 2000, 49:500–503.

    Article  PubMed  CAS  Google Scholar 

  51. Freedman BI, Yu H, Anderson PJ, et al.: Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 2000, 15:1794–1800.

    Article  PubMed  CAS  Google Scholar 

  52. Bond JS, Rojas K, Overhauser J, et al.: The structural genes, MEP1A and MEP1B, for the alpha and beta subunits of the metalloendopeptidase meprin map to human chromosomes 6p and 18q, respectively. Genomics 1995, 25:300–303.

    Article  PubMed  CAS  Google Scholar 

  53. Bond JS, Marchand P, Tang J, et al.: Structure and membrane association of mouse and rat meprins. In The Astacins: Structure and Function of a New Protein Family. Edited by Zwilling R, Stocker W. Heidelberg, Germany: Springer-Verlag Publishers; 1997:45–55.

    Google Scholar 

  54. Wolz RL, Bond JS: Meprins A and B. Methods Enzymol 1995, 248:325–345.

    Article  PubMed  CAS  Google Scholar 

  55. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977–986.

    Article  Google Scholar 

  56. Lewis EJ, Hunsisker LG, Bain RP, et al.: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993, 329:1456–1462.

    Article  PubMed  CAS  Google Scholar 

  57. Gaede P, Vedel P, Parving HH, Pedersen O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999, 353:617–622.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, MS-K10, 30341, Atlanta, GA, USA

    Giuseppina Imperatore MD, PhD

Authors
  1. Giuseppina Imperatore MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William C. Knowler MD, DrPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert G. Nelson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert L. Hanson MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Imperatore, G., Knowler, W.C., Nelson, R.G. et al. Genetics of diabetic nephropathy in the pima indians. Curr Diab Rep 1, 275–281 (2001). https://doi.org/10.1007/s11892-001-0046-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-001-0046-2

Keywords

Search

Navigation